Publications by authors named "Peter Lees"

Claim this Profile
P
Pharmacokinetic-Pharmacodynamic Cutoff Values for Doxycycline in Pigs to Support the Establishment of Clinical Breakpoints for Antimicrobial Susceptibility Testing.
Pierre-Louis Toutain, Alain Bousquet-Melou, Aude A Ferran, Béatrice B Roques, Jérôme R E Del Castillo, Peter Lees

J Vet Pharmacol Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of pharmacokinetic-pharmacodynamic cutoff values of oxytetracycline in calves and adult cattle using population pharmacokinetic modeling.
Esther A Winter, Ludovic Pelligand, Pierre-Louis Toutain, Peter Lees, Aneliya Milanova

Front Microbiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic Systemic Solutions to the Wicked and Persistent Problem of the Unprofessional Disruptive Physician in the Health System.
Carmelle Peisah, Betsy Williams, Peter Hockey, Peter Lees, Danette Wright

Healthcare (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Occupational Exposures and Chronic Obstructive Pulmonary Disease Morbidity.
Jennifer S Rous, Peter S J Lees, Kirsten Koehler, Jessie P Buckley, Lesliam Quirós-Alcalá

J Occup Environ Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of medical leaders in integrated care systems: what can be learnt from previous research?
Lorelei Jones, Kirsten Armit, Andy Haynes, Peter Lees

BMJ Lead· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biased computation of probability of target attainment for antimicrobial drugs.
Pierre-Louis Toutain, Peggy Gandia, Ludovic Pelligand, Aude A Ferran, Peter Lees

CPT Pharmacometrics Syst Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the impact of a national strategic leader development programme for UK doctors: myth-busting, mind-changing, mood-enhancing.
Judy McKimm, Peter Lees, Kirsten Armit, Chloe Mills

BMJ Lead· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
Peter Lees, Pierre-Louis Toutain, Jonathan Elliott, Jerome M Giraudel, Ludovic Pelligand

J Vet Pharmacol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turning tide for trainee leadership view from the faculty.
Peter Lees, Donna Hickford

BMJ Lead· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting and learning from leadership research: 10 years on.
Peter Lees, Kirsten Armit

BMJ Lead· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Decline and Fall of Materia Medica and the Rise of Pharmacology and Therapeutics in Veterinary Medicine.
Peter Lees, Wolfgang Bäumer, Pierre-Louis Toutain

Front Vet Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A history of antimicrobial drugs in animals: Evolution and revolution.
Peter Lees, Ludovic Pelligand, Etienne Giraud, Pierre-Louis Toutain

J Vet Pharmacol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal.
Pierre-Louis Toutain, Ludovic Pelligand, Peter Lees, Alain Bousquet-Mélou, Aude A Ferran

J Vet Pharmacol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to Yu et al.: "Levothyrox New and Old Formulations: Are They Switchable for Millions of Patients?".
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to Lechat et al.: "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk Assessment.
Harvey Checkoway, Peter S J Lees, Linda D Dell, P Robinan Gentry, Kenneth A Mundt

Risk Anal· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to Coste et al.: "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to Nicolas: "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply to Castello-Bridoux et al.: "Comment on Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author's Reply to Trechot: "Comment on Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees

Clin Pharmacokinet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and Dose Fractionation for Calf Respiratory Pathogens.
Ludovic Pelligand, Peter Lees, Pritam Kaur Sidhu, Pierre-Louis Toutain

Front Microbiol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle.
Pierre-Louis Toutain, Pritam Kaur Sidhu, Peter Lees, Ali Rassouli, Ludovic Pelligand

Front Microbiol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis